English
简体中文
Français
Deutsch
हिन्दी
Italiano
日本語
Português
Русский
Español
Türkçe
By Josh Beckerman
Two days after a massive surge following its earnings report, Invitae Corp. was up 26% to $5.70, posting its third consecutive day of volume over 100 million shares.
The medical genetics company’s shares closed at $2.29 Tuesday, rising 277% the next day to $8.63 and declining to a Thursday close of $4.51.
Invitae said in its Tuesday afternoon earnings report that it had “improvements in several key metrics focusing on non-GAAP gross margin, operating expense and cash burn trajectory.”
Write to Josh Beckerman at josh.beckerman@wsj.com
Read the full article here
